No difference in the frequency of locus-specific methylation in the peripheral blood DNA of women diagnosed with breast cancer and age-matched controls

Future Oncology

Volumn 7, Issue 12, 2011, Pages 1451-1455

  Wojdacz, Tomasz K ^a,b,c   Thestrup, Britta B ^a   Cold, Søren ^d   Overgaard, Jens ^b   Hansen, Lise L ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Lundbeck Foundation Centre for International Research in Radiation Oncology (CIRRO)   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

APC; BRCA1; BRCA2; cancer predisposition; methylation; MS HRM; RAR; RASSF1A

Indexed keywords

APC PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ARTICLE; BREAST CANCER; CANCER RISK; DNA METHYLATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; LEUKOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; PROMOTER REGIONS, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 82455188118     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.11.123     Document Type: Article

References (21)

1. Dobrovic A, Kristensen LS. DNA methylation, epimutations and cancer predisposition. Int. J. Biochem. Cell Biol. 41(1), 34-39 (2009).
2. Ligtenberg MJ, Kuiper RP, Chan TL et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3́ exons of TACSTD1. Nat. Genet. 41(1), 112-117 (2009).
3. Chan TL, Yuen ST, Kong CK et al. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat. Genet. 38(10), 1178-1183 (2006).
4. Morak M, Schackert HK, Rahner N et al. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC. Eur. J. Hum. Genet. 16(7), 804-811 (2008).
5. Hitchins MP, Wong JJ, Suthers G et al. Inheritance of a cancer-associated MLH1 germ-line epimutation. N. Engl. J. Med. 356(7), 697-705 (2007).
6. Hitchins MP, Ward RL. Erasure of MLH1 methylation in spermatozoa- implications for epigenetic inheritance. Nat. Genet. 39(11), 1289 (2007).
7. Ng SF, Lin RC, Laybutt DR, Barres R, Owens JA, Morris MJ. Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature 467(7318), 963-966 (2012).
8. Carone BR, Fauquier L, Habib N et al. Paternally induced transgenerational environmental reprogramming of metabolic gene expression in mammals. Cell 143(7), 1084-1096 (2010).
9. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat. Rev. 8(4), 253-262 (2007).
10. Wong EM, Southey MC, Fox SB et al. Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer. Cancer Prev. Res. (Phila.) 4(1), 23-33 (2011).
11. Hou L, Wang H, Sartori S et al. Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population. Int. J. Cancer 127(8), 1866-1874 (2010).
12. Snell C, Krypuy M, Wong EM, Loughrey MB, Dobrovic A. BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res. 10(1), R12 (2008).
13. Iwamoto T, Yamamoto N, Taguchi T, Tamaki Y, Noguchi S. BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation. Breast Cancer Res. Treat. 129(1), 69-77 (2011).
14. Widschwendter M, Apostolidou S, Raum E et al. Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS ONE 3(7), E2656 (2008).
15. Hansen LL, Andersen J, Overgaard J, Kruse TA. Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement. APMIS 106(3), 371-377 (1998).
16. Wojdacz TK, Dobrovic A, Hansen LL. Methylation-sensitive high-resolution melting. Nat. Protoc. 3(12), 1903-1908 (2008).
17. Wojdacz TK, Borgbo T, Hansen LL. Primer design versus PCR bias in methylation independent PCR amplifications. Epigenetics 4(4), 231-234 (2009).
18. Wojdacz TK, Moller TH, Thestrup BB, Kristensen LS, Hansen LL. Limitations and advantages of MS-HRM and bisulfite sequencing for single locus methylation studies. Expert Rev. Mol. Diagn. 10(5), 575-580 (2010).
19. Reinert T, Modin C, Castano FM et al. Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers. Clin. Cancer Res. 17(17), 5582-5592 (2011).
20. Oster B, Thorsen K, Lamy P et al. Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. Int. J. Cancer 129(12), 2855-2866 (2011).
21. PubMeth: reviewed methylation database in cancer home page. www.pubmeth.org (Accessed 13 October 2011)